| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A combination therapy with transarterial chemo-lipiodolization and systemic chemo-infusion for large extensive hepatocellular carcinoma invading portal vein in comparison with conservative management
|
Jang, Jeong Won
|
|
2006
|
59 |
1 |
p. 9-15
|
artikel
|
| 2 |
Amifostine and glutathione prevent ifosfamide- and acrolein-induced hemorrhagic cystitis
|
Batista, C. K. L. P.
|
|
2006
|
59 |
1 |
p. 71-77
|
artikel
|
| 3 |
A pharmacokinetic and safety study of a novel polymeric paclitaxel formulation for oral application
|
Veltkamp, S. A.
|
|
2006
|
59 |
1 |
p. 43-50
|
artikel
|
| 4 |
A phase I clinical and pharmacokinetic study of the multi-drug resistance protein-1 (MRP-1) inhibitor sulindac, in combination with epirubicin in patients with advanced cancer
|
O’Connor, R.
|
|
2006
|
59 |
1 |
p. 79-87
|
artikel
|
| 5 |
A phase I–II study of bi-weekly gemcitabine and irinotecan as second-line chemotherapy in non-small cell lung cancer after prior taxane + platinum-based regimens
|
Kosmas, Christos
|
|
2006
|
59 |
1 |
p. 51-59
|
artikel
|
| 6 |
A phase I study of the safety and pharmacokinetics of edotecarin (J-107088), a novel topoisomerase I inhibitor, in patients with advanced solid tumors
|
Hurwitz, Herbert I.
|
|
2006
|
59 |
1 |
p. 139-147
|
artikel
|
| 7 |
Combination therapy of human pancreatic cancer implanted in nude mice by oral fluoropyrimidine anticancer agent (S-1) with interferon-alpha
|
Miyake, Kotaro
|
|
2006
|
59 |
1 |
p. 113-126
|
artikel
|
| 8 |
Early intervention with epoetin beta prevents severe anaemia in patients with solid tumours receiving platinum-based chemotherapy: results of the NeoPrevent study
|
Castro, Javier de
|
|
2006
|
59 |
1 |
p. 35-42
|
artikel
|
| 9 |
Fatality involving vinblastine overdose as a result of a complex medical error
|
Kłys, Małgorzata
|
|
2006
|
59 |
1 |
p. 89-95
|
artikel
|
| 10 |
Monocyte fructose 1,6-bisphosphatase and cytidine deaminase enzyme activities: potential pharmacodynamic measures of calcitriol effects in cancer patients
|
Muindi, Josephia R.
|
|
2006
|
59 |
1 |
p. 97-104
|
artikel
|
| 11 |
Negative results of an Italian Group for Mesothelioma (G.I.Me.) pilot study of single-agent imatinib mesylate in malignant pleural mesothelioma
|
Porta, Camillo
|
|
2006
|
59 |
1 |
p. 149-150
|
artikel
|
| 12 |
Novel tetrahydroisoquinolin-ethyl-phenylamine based multidrug resistance inhibitors with broad-spectrum modulating properties
|
Jekerle, Veronika
|
|
2006
|
59 |
1 |
p. 61-69
|
artikel
|
| 13 |
Pharmacokinetics and tumor uptake of a derivatized form of paclitaxel associated to a cholesterol-rich nanoemulsion (LDE) in patients with gynecologic cancers
|
Dias, Maria L. N.
|
|
2006
|
59 |
1 |
p. 105-111
|
artikel
|
| 14 |
Phase II study of docetaxel and cisplatin combination chemotherapy in metastatic gastric cancer
|
Park, Keon Woo
|
|
2006
|
59 |
1 |
p. 17-21
|
artikel
|
| 15 |
Phase II trial of a 2-h infusion of gemcitabine plus carboplatin as first-line chemotherapy for advanced non-small-cell lung cancer
|
Xu, N.
|
|
2006
|
59 |
1 |
p. 1-7
|
artikel
|
| 16 |
RNAi-mediated knockdown of aldehyde dehydrogenase class-1A1 and class-3A1 is specific and reveals that each contributes equally to the resistance against 4-hydroperoxycyclophosphamide
|
Moreb, Jan S.
|
|
2006
|
59 |
1 |
p. 137
|
artikel
|
| 17 |
RNAi-mediated knockdown of aldehyde dehydrogenase class-1A1 and class-3A1 is specific and reveals that each contributes equally to the resistance against 4-hydroperoxycyclophosphamide
|
Moreb, Jan S.
|
|
2006
|
59 |
1 |
p. 127-136
|
artikel
|
| 18 |
Thalidomide and celecoxib as potential modulators of irinotecan’s activity in cancer patients
|
Villalona-Calero, Miguel
|
|
2006
|
59 |
1 |
p. 23-33
|
artikel
|
Tijdschrift beschrijving